International
The impact of EMCDDA cannabis legislation changes on the EU industry
The evolving cannabis policy landscape in Europe presents a number of challenges and opportunities for Member States. With changing attitudes towards cannabis and deepening scientific knowledge, it is increasingly recognized that policy must adapt in line with science. The transformation of European Monitoring Center for Drugs and Drug Addiction (EMCDDA) European Drugs Agency (EUDA) reflects this shift, with a renewed emphasis on supporting decision-makers in defining cannabis policies based on evidence and best practice.
Several European countries have already taken steps forward in reforming their cannabis laws, such as Malta, Luxembourg and the Netherlands, while others, such as Germany and the Czech Republic, are about to follow suit. These changes highlight a move towards more evidence-based and nuanced approaches to cannabis regulation.
The EMCDDA/EUDA is poised to play a key role in this process by providing data, analysis and support to help formulate and evaluate cannabis policies. This includes the development of a comprehensive “cannabis policy toolkit” designed to equip decision-makers with the resources they need to make informed choices tailored to the needs of their country.
Additionally, the agency's efforts go beyond cannabis policy to disseminate knowledge about the medical use of controlled psychedelic substances. With growing interest in the therapeutic potential of psychedelic substances, initiatives such as research funding and regulatory guidance aim to ensure safe and effective use while mitigating potential harm.
In the coming years, the EMCDDA/EUDA mandate will continue to evolve in response to emerging drug policy trends and challenges. By fostering collaboration, disseminating evidence-based information and supporting policy development and implementation, the agency is poised to drive significant progress in protecting the health and well-being of EU citizens.
____________________________________________________________________________________________________
[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]____________________________________________________________________________________________________
What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!
With a professional background in CAD technical drawing (2D and 3D), João Xabregas is an activist and advocate for all uses and applications of cannabis. He discovered and entered the world of cannabis during his youth, where he developed a special interest in the cultivation of the plant, which led him on a journey of self-learning through the world of cannabis that continues to this day. His adventures linked to cannabis cultivation began with the same goal as many others: to be able to guarantee the quality and eliminate any possible risks to his health of what he consumed, as well as to avoid any type of dependence on the illicit market. However, he quickly began to view the world of cannabis and everything related to it with a very different perspective. He admits the enormous passion he has for the most persecuted plant in the world and about which he is always willing to write and have a good conversation.
Thailand has found a solution where European countries still see a problem.
Reading Time: 13 minutes On my second trip to Thailand, I was once again pleasantly surprised. After visiting several...
The Royal Thai Embassy in Tokyo promotes "Adapting International Hemp to Japan's New Regulations"
Reading Time: 3 minutes The International Business Meeting “Adapting the International Market...” will take place tomorrow, November 13, 2025.
Portugal: Infarmed updates lists and removes licenses from two more medicinal cannabis companies.
Reading Time: 2 minutes. Infarmed has updated the public list of entities licensed for activities with medicinal cannabis in Portugal. The...
Portocanna strengthens its Hexacan portfolio with a new sublingual solution containing 20% THC.
Reading Time: 2 minutes. The Portuguese company Portocanna announced the launch of Hexacan® Hexa 01 Cannabis Oil Extract THC 20%,...
Cypress Hill confirmed for Rock in Rio Lisboa 2026
Reading Time: 2 minutes. The legendary American band Cypress Hill, whose hits "Insane in the Brain" and "Hits from the Bong"...
USA: Green Thumb Industries workers secure collective agreement after 45-day strike.
Reading Time: < 1 minute Workers at Green Thumb Industries, one of the largest multi-state cannabis companies in the United States...
Switzerland: Pacrim takes control of Medropharm and prepares for a new phase of expansion in medicinal cannabis.
Reading Time: 2 minutes. Pacrim has acquired two-thirds of the Swiss company Medropharm, thus gaining control of the company and its operations.
South Africa: Researchers discover rare phenolic compounds in cannabis leaves.
Reading Time: 4 minutes. Researchers at Stellenbosch University in South Africa have discovered that flavoalkaloids are produced in the leaves of the plant...
Covilhã – Dismantling of two cannabis greenhouses
Reading Time: < 1 minute The Castelo Branco Territorial Command, through the Criminal Investigation Unit (NIC) of Covilhã, in...
Tokyo will host the Japan International Hemp Expo on November 14th and 15th, 2025.
Reading Time: 4 minutes. For the first time since the legal reform, Japan opens its doors to the global hemp industry...
